組織因子誘発ラットDICモデルに対するグリコサミノグリカン鎖付加型可溶性ヒトトロンボモジュリン (GAG-UTM) の臓器内血栓形成抑制作用

書誌事項

タイトル別名
  • Antithrombotic Effect of Glycosaminoglycan-modified Urinary Thrombomodulin (GAG-UTM) on Tissue factor-induced DIC Rats

この論文をさがす

抄録

The anticoagulant and antithrombotic effects of a glycosaminoglycan-modified urinary thrombomodulin (GAG-UTM) expressed in C-127 cells were investigated.<br>Among several species of blood tested, GAG-UTM induced a 2-fold prolongation at 0.24μg/ml in human whole blood clotting time.<br>Following the injection of 125I-fibrinogen, the rat was infused with Tissue factor (TF) 30mg/kg/hr intravenously (i.v.), and the macro-autoradiogram was conducted. Marked accumulations of 125I-fibrin comprising microthrombi were observed in major organs such as kidney, spleen, liver and lung. The tissue/blood (T/B) ratio of the radioactivity was used to indicate the distribution of thrombi. TF infusion gave rise to 1.1 through 4.7 in the T/B values.<br>In the above treatment, i.v. infusion of GAG-UTM (10 to 300μg/kg/hr) dose-dependently decreased the T/B values. Moreover, significant improvement of the platelet counts and plasma fibrinogen levels were induced by GAG-UTM administration (more than 30μg/kg/hr).<br>Those results indicate that GAG-UTM shows an excellent inhibitory effect on TF-induced thrombus formation, and it markedly normalizes the bleeding tendency caused by TF-infusion.<br>It seems that GAG-UTM may be a potent antithrombotic agent without affecting bleeding tendency in clinical use.

収録刊行物

参考文献 (21)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ